Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Addict Behav. 2011 Nov 26;37(3):306–312. doi: 10.1016/j.addbeh.2011.11.028

Table 3.

Mean scores on SF-36 scales for men by age and drug use status

Ages 45–54
Ages 55–64
Ages 65+
Total (n = 39) No Past-year Drug Use (n = 16) Past-year Drug Use (n = 23) Total (n = 129) No Past-year Drug Use (n = 59) Past-year Drug Use (n = 70) Total (n = 23) No Past-year Drug Use (n = 13) Past-year Drug Use (n = 10)



Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Physical functioning 67.05 (27.93) 77.81 (24.42) 59.57 (28.24) 66.23** (29.47) 63.31 (31.60) 68.69 (27.54) 64.57 (29.88) 63.46 (30.03) 66.00 (31.25)
Role functioning physical 48.72** (41.73) 57.81 (42.54) 42.39 (40.90) 55.04*** (43.46) 53.81 (44.48) 56.07 (42.87) 66.30 (44.98) 76.92 (38.81) 52.50 (50.62)
Bodily pain 61.15* (27.90) 66.09 (31.41) 57.72 (25.34) 63.76* (28.09) 57.16 (26.67) 69.32 (28.24) 63.70 (29.33) 61.35 (31.17) 66.75 (28.09)
General health 51.15** (22.98) 56.25 (21.41) 47.61 (23.83) 50.35*** (23.16) 48.90 (23.34) 51.57 (23.10) 58.70 (19.08) 55.00 (18.71) 63.50 (19.44)
Energy & fatigue 45.90** (20.93) 47.81 (21.98) 44.57 (20.56) 48.06*** (20.40) 47.20 (21.18) 48.79 (19.84) 57.39 (22.15) 53.46 (22.95) 62.50 (21.11)
Social functioning 68.27** (27.03) 74.22 (29.04) 64.13 (25.37) 71.03*** (26.97) 67.58 (26.98) 73.93 (26.81) 74.46 (26.51) 74.04 (24.72) 75.00 (30.05)
Role functioning emotional 68.38 (45.21) 77.08 (39.85) 62.32 (48.52) 68.73 (41.61) 64.97 (43.95) 71.90 (39.58) 84.06 (34.63) 82.05 (37.55) 86.67 (32.20)
Emotional well-being 67.38 (20.59) 67.75 (23.53) 67.13 (18.84) 68.16** (19.78) 69.42 (18.95) 67.09 (20.53) 78.61 (13.13) 77.23 (13.50) 80.40 (13.13)

SF-36 scale scores range from 0–100, with higher scores indicating better functioning; significance tests indicate difference between sample mean and population norm by gender and age group.

*

p < .05,

**

p < .01,

***

p < .001.

Difference between drug-use group means, p < .05.

HHS Vulnerability Disclosure